Remodelling of high density lipoproteins by plasma factors

被引:224
作者
Rye, KA
Clay, MA
Barter, PJ
机构
[1] Royal Adelaide Hosp, Div Cardiovasc Sci, Lipid Res Lab, Hanson Ctr, Adelaide, SA 5000, Australia
[2] Univ Adelaide, Dept Med, Royal Adelaide Hosp, Adelaide, SA 5001, Australia
关键词
high density lipoproteins; remodelling; plasma factors; apolipoprotein A-I; apolipoprotein A-II;
D O I
10.1016/S0021-9150(99)00150-1
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Evidence that the high density lipoproteins (HDL) in human plasma are antiatherogenic has stimulated considerable interest in the factors which regulate their structure and function. Plasma HDL consist of a number of subpopulations of particles of varying size, density and composition. This structural heterogeneity is caused by the continual remodelling of individual HDL subpopulations by various plasma factors. One of the consequences of this remodelling is that the HDL subpopulations in plasma are functionally diverse, particularly in terms of their antiatherogenic properties. This review documents what is currently known about the interaction of HDL with plasma factors and presents an overview of the remodelling of HDL which occurs as a consequence of those interactions. (C) 1999 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:227 / 238
页数:12
相关论文
共 140 条
  • [1] Identification of scavenger receptor SR-BI as a high density lipoprotein receptor
    Acton, S
    Rigotti, A
    Landschulz, KT
    Xu, SZ
    Hobbs, HH
    Krieger, M
    [J]. SCIENCE, 1996, 271 (5248) : 518 - 520
  • [2] AGELLON LB, 1991, J BIOL CHEM, V266, P10796
  • [3] FUNCTIONAL EXPRESSION OF HUMAN AND MOUSE PLASMA PHOSPHOLIPID TRANSFER PROTEIN - EFFECT OF RECOMBINANT AND PLASMA PLTP ON HDL SUBSPECIES
    ALBERS, JJ
    WOLFBAUER, G
    CHEUNG, MC
    DAY, JR
    CHING, AFT
    LOK, S
    TU, AY
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-LIPIDS AND LIPID METABOLISM, 1995, 1258 (01): : 27 - 34
  • [4] Hepatic lipase gene therapy in hepatic lipase-deficient mice - Adenovirus-mediated replacement of a lipolytic enzyme to the vascular endothelium
    ApplebaumBowden, D
    Kobayashi, J
    Kashyap, VS
    Brown, DR
    Berard, A
    Meyn, S
    Parrott, C
    Maeda, N
    Shamburek, R
    Brewer, HB
    SantamarinaFojo, S
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1996, 97 (03) : 799 - 805
  • [5] Cholesterol efflux potential of sera from mice expressing human cholesteryl ester transfer protein and/or human apolipoprotein Al
    Atger, V
    delaLleraMoya, M
    Bamberger, M
    Francone, O
    Cosgrove, P
    Tall, A
    Walsh, A
    Moatti, N
    Rothblat, G
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1995, 96 (06) : 2613 - 2622
  • [6] Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions - A possible peroxidative role for paraoxonase
    Aviram, M
    Rosenblat, M
    Bisgaier, CL
    Newton, RS
    Primo-Parmo, SL
    La Du, BN
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1998, 101 (08) : 1581 - 1590
  • [7] ACCELERATED CHOLESTERYL ESTER TRANSFER IN NONINSULIN-DEPENDENT DIABETES-MELLITUS
    BAGDADE, JD
    LANE, JT
    SUBBAIAH, PV
    OTTO, ME
    RITTER, MC
    [J]. ATHEROSCLEROSIS, 1993, 104 (1-2) : 69 - 77
  • [8] ABNORMAL LIPOPROTEIN PHOSPHOLIPID-COMPOSITION IN PATIENTS WITH ESSENTIAL-HYPERTENSION
    BAGDADE, JD
    BUCHANAN, WF
    POLLARE, T
    LITHELL, H
    [J]. ATHEROSCLEROSIS, 1995, 117 (02) : 209 - 215
  • [9] BARRANS A, 1994, J BIOL CHEM, V269, P11572
  • [10] BARTER PJ, 1982, BIOCHEM J, V208, P1